Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform.

Pharmaceutical

Morphic Therapeutic

Praveen Tipirneni

Matt Bursavich

Hanh Nguyen

Joanne Gibbons

Carolyn Soo

Aaron Pelta

Brihad Abhyankar

Jeff Handler

Chris Erdman

William DeVaul

Blaise Lippa

Bruce Rogers

Marc Schegerin

The Scientific & Clinical Development Team at Morphic Therapeutic is responsible for the strategic planning and execution of clinical trials and scientific research to advance the development of oral integrin drugs. They ensure the safety, efficacy, and bioanalytical evaluation of the compounds, leveraging their expertise in chemistry, pharmacology, and safety assessment to drive successful drug development.

Scientific & Clinical Development Team

Scientific and Clinical Research Team

Director

Clinical Operations Team

Scientific & Clinical Development Team

About

Team members

Other teams at Morphic Therapeutic

Scientific and Clinical Research Team

Director

Clinical Operations Team